phosphoserine and mdl 201053

phosphoserine has been researched along with mdl 201053 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bayon, Y; Lopez-Hernandez, FJ; Ortiz, MA; Piedrafita, FJ	1

Other Studies

1 other study(ies) available for phosphoserine and mdl 201053

Article	Year
Z-FA-fmk inhibits effector caspases but not initiator caspases 8 and 10, and demonstrates that novel anticancer retinoid-related molecules induce apoptosis via the intrinsic pathway. Molecular cancer therapeutics, 2003, Volume: 2, Issue:3 Topics: Amino Acid Chloromethyl Ketones; Annexin A5; Antineoplastic Agents; Apoptosis; Biotinylation; Caspase Inhibitors; Caspases; Cathepsins; Cysteine Proteinase Inhibitors; Cytochromes c; Dipeptides; fas Receptor; Humans; Jurkat Cells; Ketones; Peptide Fragments; Peptide Hydrolases; Phosphoserine; Retinoids	2003

Article

Year

Z-FA-fmk inhibits effector caspases but not initiator caspases 8 and 10, and demonstrates that novel anticancer retinoid-related molecules induce apoptosis via the intrinsic pathway.

Molecular cancer therapeutics, 2003, Volume: 2, Issue:3

Topics: Amino Acid Chloromethyl Ketones; Annexin A5; Antineoplastic Agents; Apoptosis; Biotinylation; Caspase Inhibitors; Caspases; Cathepsins; Cysteine Proteinase Inhibitors; Cytochromes c; Dipeptides; fas Receptor; Humans; Jurkat Cells; Ketones; Peptide Fragments; Peptide Hydrolases; Phosphoserine; Retinoids

2003